# Artichoke Blood Pressure Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/artichoke-blood-pressure-meta-analysis-evidence-review
Category: evidence-review
Summary: Artichoke Blood Pressure Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are 
Last reviewed: 2026-06-27
Reviewed by: Migaku Evidence Review
# Artichoke Blood Pressure Meta-analysis: What the Evidence Says

## Quick Answer

Artichoke Blood Pressure Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 narrative review, 1 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Exploring the Cardiovascular Potential of Artichoke—A Comprehensive Review | narrative review | 3 | 2025-04-10 | 10.3390/biology14040397 |
| Protecting Citizens, Enabling Prevention: A Framework for Responsible Dietary Supplement Use in Europe | research article | 4 | 2026-02-25 | 10.3390/nu18050729 |

## What The Sources Report

- Cardiovascular diseases are highly prevalent worldwide, particularly in developed countries, and are associated with significant mortality, morbidity, and substantial healthcare costs. [Silva Henrique (2025); evidence level 3]
- As the prevalence of cardiovascular diseases is expected to rise in the coming decades, the implementation of preventive strategies becomes imperative to slow disease progression and mitigate associated complications. [Silva Henrique (2025); evidence level 3]
- A useful way to frame this is through Geoffrey Rose's population principle: "a large number of people at a small risk may give rise to more cases of disease than a small number who are at a high risk". [Cicero Arrigo F. G. (2026); evidence level 4]
- The practical implication is that Europe's most powerful prevention gains will come not only from identifying the highest-risk citizens, but also from gently shifting whole distributions-blood pressure, low-density lipoprotein cholesterol (LDL-C), glycaemia, adiposity-towards healthier ranges. [Cicero Arrigo F. G. (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For artichoke blood pressure meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Silva Henrique (2025). Exploring the Cardiovascular Potential of Artichoke—A Comprehensive Review. DOI: 10.3390/biology14040397. PMCID: PMC12024969. PMID: 40282262. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12024969/
- Cicero Arrigo F. G. (2026). Protecting Citizens, Enabling Prevention: A Framework for Responsible Dietary Supplement Use in Europe. DOI: 10.3390/nu18050729. PMCID: PMC12986882. PMID: 41829899. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12986882/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.